Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 11.8 | % | PubChem BioAssay data set |
NPT2574 | Individual Protein | Insulin receptor | Homo sapiens | IC50 | > | 10 | ug/ml | 23376010 |
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | IC50 | > | 10 | ug/ml | Open TG-GATES in vivo data: Biochemistry |
NPT1598 | Individual Protein | Casein kinase II alpha | Homo sapiens | IC50 | > | 10 | ug/ml | Open TG-GATES in vivo data: Hematology |
NPT1702 | Individual Protein | Serine/threonine-protein kinase PLK4 | Homo sapiens | IC50 | > | 10 | ug/ml | 18370373 |
NPT2571 | Individual Protein | Mitogen-activated protein kinase kinase kinase 8 | Homo sapiens | IC50 | > | 10 | ug/ml | 20605448 |
NPT2213 | Individual Protein | Cyclin-dependent kinase 4 | Homo sapiens | IC50 | > | 10 | ug/ml | 20605448 |
NPT286 | Individual Protein | Receptor protein-tyrosine kinase erbB-2 | Homo sapiens | IC50 | > | 10 | ug/ml | 20605448 |
NPT1436 | Individual Protein | Focal adhesion kinase 1 | Homo sapiens | IC50 | > | 10 | ug/ml | 20491440 |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | IC50 | > | 10 | ug/ml | 24900575 |
NPT2572 | Individual Protein | Ephrin type-B receptor 4 | Homo sapiens | IC50 | > | 10 | ug/ml | 24063567 |
NPT1478 | Individual Protein | Vascular endothelial growth factor receptor 2 | Homo sapiens | IC50 | > | 10 | ug/ml | 21324686 |
NPT2 | Others | Unspecified | IC50 | > | 10 | ug/ml | PubChem BioAssay data set | |
NPT728 | Individual Protein | Serine/threonine-protein kinase AKT | Homo sapiens | IC50 | > | 10 | ug/ml | 8254344 |
NPT2576 | Individual Protein | Tyrosine-protein kinase TIE-2 | Homo sapiens | IC50 | > | 10 | ug/ml | 24164245 |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | IC50 | > | 10 | ug/ml | 18327910 |
NPT2573 | Individual Protein | Vascular endothelial growth factor receptor 3 | Homo sapiens | IC50 | > | 10 | ug/ml | 15568791 |
NPT1433 | Individual Protein | Serine/threonine-protein kinase Aurora-B | Homo sapiens | IC50 | > | 10 | ug/ml | DrugMatrix in vitro pharmacology data |
NPT1660 | Individual Protein | NUAK family SNF1-like kinase 1 | Homo sapiens | IC50 | > | 10 | ug/ml | 15711537 |
NPT1337 | Individual Protein | Hepatocyte growth factor receptor | Homo sapiens | IC50 | > | 10 | ug/ml | 19128055 |
NPT2575 | Individual Protein | Platelet-derived growth factor receptor beta | Homo sapiens | IC50 | > | 10 | ug/ml | 19128055 |
NPT1438 | Individual Protein | Insulin-like growth factor I receptor | Homo sapiens | IC50 | > | 10 | ug/ml | 11520220 |
NPT1432 | Individual Protein | Serine/threonine-protein kinase Aurora-A | Homo sapiens | IC50 | > | 10 | ug/ml | 23398362 |
NPT1371 | Individual Protein | Cyclin-dependent kinase 2 | Homo sapiens | IC50 | > | 10 | ug/ml | Open TG-GATES in vivo data: Biochemistry |
NPT1650 | Individual Protein | Tyrosine-protein kinase receptor FLT3 | Homo sapiens | IC50 | > | 10 | ug/ml | 15646539 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC204350 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9653 | High Similarity | NPC138978 |
0.9338 | High Similarity | NPC227062 |
0.9281 | High Similarity | NPC200594 |
0.9272 | High Similarity | NPC20541 |
0.9216 | High Similarity | NPC238381 |
0.9205 | High Similarity | NPC281477 |
0.9189 | High Similarity | NPC476463 |
0.9145 | High Similarity | NPC16082 |
0.9145 | High Similarity | NPC82592 |
0.9145 | High Similarity | NPC199926 |
0.9139 | High Similarity | NPC295646 |
0.9133 | High Similarity | NPC96501 |
0.9116 | High Similarity | NPC257025 |
0.9085 | High Similarity | NPC54928 |
0.9085 | High Similarity | NPC150227 |
0.9034 | High Similarity | NPC471819 |
0.9028 | High Similarity | NPC135837 |
0.9026 | High Similarity | NPC84935 |
0.9026 | High Similarity | NPC190020 |
0.9026 | High Similarity | NPC77679 |
0.902 | High Similarity | NPC67396 |
0.902 | High Similarity | NPC79998 |
0.902 | High Similarity | NPC38898 |
0.902 | High Similarity | NPC471800 |
0.9013 | High Similarity | NPC167903 |
0.9007 | High Similarity | NPC119929 |
0.9007 | High Similarity | NPC85131 |
0.8993 | High Similarity | NPC267509 |
0.8981 | High Similarity | NPC156082 |
0.898 | High Similarity | NPC250755 |
0.8968 | High Similarity | NPC83763 |
0.8968 | High Similarity | NPC168616 |
0.8968 | High Similarity | NPC45846 |
0.8961 | High Similarity | NPC24640 |
0.8958 | High Similarity | NPC223836 |
0.8947 | High Similarity | NPC202157 |
0.894 | High Similarity | NPC270160 |
0.894 | High Similarity | NPC237440 |
0.8926 | High Similarity | NPC134621 |
0.8926 | High Similarity | NPC32470 |
0.8924 | High Similarity | NPC112981 |
0.8924 | High Similarity | NPC8070 |
0.8919 | High Similarity | NPC469542 |
0.8919 | High Similarity | NPC51106 |
0.8919 | High Similarity | NPC287722 |
0.8912 | High Similarity | NPC67650 |
0.8912 | High Similarity | NPC1704 |
0.8912 | High Similarity | NPC220106 |
0.8912 | High Similarity | NPC90411 |
0.8889 | High Similarity | NPC289968 |
0.8889 | High Similarity | NPC28103 |
0.8889 | High Similarity | NPC199773 |
0.8889 | High Similarity | NPC180905 |
0.8889 | High Similarity | NPC182496 |
0.8882 | High Similarity | NPC151473 |
0.8874 | High Similarity | NPC321011 |
0.8874 | High Similarity | NPC188679 |
0.8874 | High Similarity | NPC294852 |
0.8868 | High Similarity | NPC20216 |
0.8867 | High Similarity | NPC260946 |
0.8867 | High Similarity | NPC237208 |
0.8861 | High Similarity | NPC300984 |
0.8859 | High Similarity | NPC66404 |
0.8859 | High Similarity | NPC210425 |
0.8859 | High Similarity | NPC95123 |
0.8859 | High Similarity | NPC86373 |
0.8859 | High Similarity | NPC280404 |
0.8859 | High Similarity | NPC277426 |
0.8859 | High Similarity | NPC242893 |
0.8859 | High Similarity | NPC38065 |
0.8854 | High Similarity | NPC303565 |
0.8851 | High Similarity | NPC301178 |
0.8851 | High Similarity | NPC284556 |
0.8851 | High Similarity | NPC105648 |
0.8846 | High Similarity | NPC315157 |
0.8846 | High Similarity | NPC85121 |
0.8846 | High Similarity | NPC329091 |
0.8846 | High Similarity | NPC210459 |
0.8831 | High Similarity | NPC89474 |
0.8831 | High Similarity | NPC93552 |
0.8824 | High Similarity | NPC215921 |
0.8824 | High Similarity | NPC70016 |
0.8816 | High Similarity | NPC1612 |
0.8816 | High Similarity | NPC183959 |
0.8812 | High Similarity | NPC272485 |
0.8812 | High Similarity | NPC292788 |
0.8808 | High Similarity | NPC108406 |
0.8805 | High Similarity | NPC267153 |
0.88 | High Similarity | NPC29577 |
0.8797 | High Similarity | NPC93739 |
0.8792 | High Similarity | NPC175013 |
0.8792 | High Similarity | NPC472006 |
0.8792 | High Similarity | NPC471417 |
0.879 | High Similarity | NPC24627 |
0.879 | High Similarity | NPC471744 |
0.879 | High Similarity | NPC321399 |
0.879 | High Similarity | NPC292415 |
0.879 | High Similarity | NPC36217 |
0.8782 | High Similarity | NPC111969 |
0.8782 | High Similarity | NPC247713 |
0.8782 | High Similarity | NPC241904 |
0.8782 | High Similarity | NPC300727 |
0.8776 | High Similarity | NPC134969 |
0.8776 | High Similarity | NPC247409 |
0.8774 | High Similarity | NPC80534 |
0.8774 | High Similarity | NPC16286 |
0.8774 | High Similarity | NPC56786 |
0.8773 | High Similarity | NPC139350 |
0.8766 | High Similarity | NPC260979 |
0.8766 | High Similarity | NPC175978 |
0.8766 | High Similarity | NPC106976 |
0.8766 | High Similarity | NPC273483 |
0.8766 | High Similarity | NPC302950 |
0.8766 | High Similarity | NPC219582 |
0.8766 | High Similarity | NPC236637 |
0.8758 | High Similarity | NPC469619 |
0.8758 | High Similarity | NPC62042 |
0.8758 | High Similarity | NPC469670 |
0.8758 | High Similarity | NPC470107 |
0.8758 | High Similarity | NPC26568 |
0.8758 | High Similarity | NPC10467 |
0.875 | High Similarity | NPC80710 |
0.875 | High Similarity | NPC203747 |
0.875 | High Similarity | NPC254702 |
0.875 | High Similarity | NPC203077 |
0.875 | High Similarity | NPC3036 |
0.875 | High Similarity | NPC194653 |
0.875 | High Similarity | NPC287395 |
0.875 | High Similarity | NPC107636 |
0.875 | High Similarity | NPC218490 |
0.875 | High Similarity | NPC119059 |
0.875 | High Similarity | NPC183655 |
0.875 | High Similarity | NPC120464 |
0.875 | High Similarity | NPC139364 |
0.875 | High Similarity | NPC172329 |
0.875 | High Similarity | NPC166036 |
0.875 | High Similarity | NPC2569 |
0.875 | High Similarity | NPC238279 |
0.875 | High Similarity | NPC472452 |
0.875 | High Similarity | NPC153783 |
0.8742 | High Similarity | NPC32058 |
0.8742 | High Similarity | NPC284007 |
0.8742 | High Similarity | NPC107625 |
0.8742 | High Similarity | NPC163846 |
0.8742 | High Similarity | NPC234004 |
0.8742 | High Similarity | NPC225173 |
0.8742 | High Similarity | NPC85734 |
0.8734 | High Similarity | NPC473106 |
0.8734 | High Similarity | NPC349525 |
0.8734 | High Similarity | NPC112418 |
0.8734 | High Similarity | NPC103201 |
0.8733 | High Similarity | NPC279121 |
0.8726 | High Similarity | NPC37502 |
0.8726 | High Similarity | NPC470339 |
0.8726 | High Similarity | NPC476242 |
0.8726 | High Similarity | NPC40702 |
0.8726 | High Similarity | NPC267627 |
0.8725 | High Similarity | NPC182255 |
0.8725 | High Similarity | NPC469579 |
0.8725 | High Similarity | NPC94076 |
0.8725 | High Similarity | NPC474385 |
0.8725 | High Similarity | NPC82913 |
0.8718 | High Similarity | NPC475799 |
0.8718 | High Similarity | NPC13779 |
0.8718 | High Similarity | NPC142339 |
0.8718 | High Similarity | NPC197751 |
0.8718 | High Similarity | NPC153512 |
0.8718 | High Similarity | NPC472456 |
0.8718 | High Similarity | NPC274730 |
0.8716 | High Similarity | NPC155205 |
0.8716 | High Similarity | NPC165172 |
0.871 | High Similarity | NPC144801 |
0.871 | High Similarity | NPC213896 |
0.871 | High Similarity | NPC291510 |
0.871 | High Similarity | NPC192083 |
0.871 | High Similarity | NPC116850 |
0.871 | High Similarity | NPC107109 |
0.871 | High Similarity | NPC469550 |
0.871 | High Similarity | NPC18727 |
0.871 | High Similarity | NPC298802 |
0.871 | High Similarity | NPC197188 |
0.871 | High Similarity | NPC192189 |
0.871 | High Similarity | NPC298692 |
0.871 | High Similarity | NPC74924 |
0.871 | High Similarity | NPC238672 |
0.871 | High Similarity | NPC43872 |
0.8704 | High Similarity | NPC10576 |
0.8704 | High Similarity | NPC1827 |
0.8704 | High Similarity | NPC17219 |
0.8704 | High Similarity | NPC239440 |
0.8704 | High Similarity | NPC20543 |
0.8704 | High Similarity | NPC246716 |
0.8701 | High Similarity | NPC200773 |
0.8701 | High Similarity | NPC204515 |
0.8701 | High Similarity | NPC227166 |
0.8701 | High Similarity | NPC240768 |
0.8701 | High Similarity | NPC45291 |
0.8701 | High Similarity | NPC272566 |
0.8701 | High Similarity | NPC19980 |
0.8699 | High Similarity | NPC235115 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC204350 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8904 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.8766 | High Similarity | NPD1934 | Approved |
0.8733 | High Similarity | NPD1511 | Approved |
0.871 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD6232 | Discontinued |
0.8618 | High Similarity | NPD1512 | Approved |
0.859 | High Similarity | NPD1465 | Phase 2 |
0.8519 | High Similarity | NPD7473 | Discontinued |
0.8493 | Intermediate Similarity | NPD230 | Phase 1 |
0.8481 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8471 | Intermediate Similarity | NPD2801 | Approved |
0.8431 | Intermediate Similarity | NPD2532 | Approved |
0.8431 | Intermediate Similarity | NPD2533 | Approved |
0.8431 | Intermediate Similarity | NPD2534 | Approved |
0.8418 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8365 | Intermediate Similarity | NPD3882 | Suspended |
0.8354 | Intermediate Similarity | NPD7819 | Suspended |
0.8322 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8299 | Intermediate Similarity | NPD1240 | Approved |
0.8232 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8232 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8232 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8212 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8212 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8193 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8188 | Intermediate Similarity | NPD1607 | Approved |
0.8176 | Intermediate Similarity | NPD943 | Approved |
0.8158 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8144 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8133 | Intermediate Similarity | NPD3818 | Discontinued |
0.8129 | Intermediate Similarity | NPD6799 | Approved |
0.8086 | Intermediate Similarity | NPD7075 | Discontinued |
0.8084 | Intermediate Similarity | NPD7054 | Approved |
0.8079 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8052 | Intermediate Similarity | NPD3750 | Approved |
0.805 | Intermediate Similarity | NPD6599 | Discontinued |
0.805 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8049 | Intermediate Similarity | NPD6959 | Discontinued |
0.8036 | Intermediate Similarity | NPD7472 | Approved |
0.8026 | Intermediate Similarity | NPD2935 | Discontinued |
0.8026 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8012 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7988 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7975 | Intermediate Similarity | NPD3749 | Approved |
0.7941 | Intermediate Similarity | NPD7251 | Discontinued |
0.7927 | Intermediate Similarity | NPD919 | Approved |
0.7927 | Intermediate Similarity | NPD6234 | Discontinued |
0.7914 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7888 | Intermediate Similarity | NPD7411 | Suspended |
0.7866 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.784 | Intermediate Similarity | NPD6801 | Discontinued |
0.7821 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.78 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7798 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD2796 | Approved |
0.7791 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7784 | Intermediate Similarity | NPD5711 | Approved |
0.7784 | Intermediate Similarity | NPD5710 | Approved |
0.7771 | Intermediate Similarity | NPD5494 | Approved |
0.7763 | Intermediate Similarity | NPD447 | Suspended |
0.7756 | Intermediate Similarity | NPD1243 | Approved |
0.775 | Intermediate Similarity | NPD920 | Approved |
0.7744 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.774 | Intermediate Similarity | NPD9269 | Phase 2 |
0.773 | Intermediate Similarity | NPD37 | Approved |
0.7727 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD3748 | Approved |
0.7727 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7725 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7718 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7707 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7697 | Intermediate Similarity | NPD1613 | Approved |
0.7697 | Intermediate Similarity | NPD4966 | Approved |
0.7697 | Intermediate Similarity | NPD4965 | Approved |
0.7697 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7667 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7654 | Intermediate Similarity | NPD3226 | Approved |
0.7643 | Intermediate Similarity | NPD2800 | Approved |
0.764 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7636 | Intermediate Similarity | NPD5402 | Approved |
0.7633 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.763 | Intermediate Similarity | NPD6559 | Discontinued |
0.7625 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7625 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7619 | Intermediate Similarity | NPD1247 | Approved |
0.7616 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7613 | Intermediate Similarity | NPD2799 | Discontinued |
0.761 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7602 | Intermediate Similarity | NPD7228 | Approved |
0.7584 | Intermediate Similarity | NPD1203 | Approved |
0.7562 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7562 | Intermediate Similarity | NPD7390 | Discontinued |
0.7558 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD5403 | Approved |
0.7529 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7516 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD5401 | Approved |
0.7516 | Intermediate Similarity | NPD2346 | Discontinued |
0.75 | Intermediate Similarity | NPD1608 | Approved |
0.7483 | Intermediate Similarity | NPD9494 | Approved |
0.7466 | Intermediate Similarity | NPD9268 | Approved |
0.7458 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7444 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7438 | Intermediate Similarity | NPD6190 | Approved |
0.7427 | Intermediate Similarity | NPD5242 | Approved |
0.7419 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD2344 | Approved |
0.74 | Intermediate Similarity | NPD1283 | Approved |
0.7399 | Intermediate Similarity | NPD3751 | Discontinued |
0.7397 | Intermediate Similarity | NPD9545 | Approved |
0.7383 | Intermediate Similarity | NPD9717 | Approved |
0.7375 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7372 | Intermediate Similarity | NPD6651 | Approved |
0.7371 | Intermediate Similarity | NPD5953 | Discontinued |
0.7368 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7356 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7342 | Intermediate Similarity | NPD5405 | Approved |
0.7342 | Intermediate Similarity | NPD6099 | Approved |
0.7342 | Intermediate Similarity | NPD5406 | Approved |
0.7342 | Intermediate Similarity | NPD5404 | Approved |
0.7342 | Intermediate Similarity | NPD6100 | Approved |
0.7342 | Intermediate Similarity | NPD5408 | Approved |
0.7338 | Intermediate Similarity | NPD3764 | Approved |
0.732 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7316 | Intermediate Similarity | NPD8151 | Discontinued |
0.7315 | Intermediate Similarity | NPD422 | Phase 1 |
0.7308 | Intermediate Similarity | NPD1933 | Approved |
0.7301 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD17 | Approved |
0.7273 | Intermediate Similarity | NPD1653 | Approved |
0.7267 | Intermediate Similarity | NPD3787 | Discontinued |
0.726 | Intermediate Similarity | NPD9493 | Approved |
0.7244 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7237 | Intermediate Similarity | NPD1164 | Approved |
0.7232 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7229 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7226 | Intermediate Similarity | NPD411 | Approved |
0.7226 | Intermediate Similarity | NPD2313 | Discontinued |
0.7222 | Intermediate Similarity | NPD2309 | Approved |
0.7219 | Intermediate Similarity | NPD4288 | Approved |
0.7219 | Intermediate Similarity | NPD5353 | Approved |
0.72 | Intermediate Similarity | NPD1201 | Approved |
0.72 | Intermediate Similarity | NPD1610 | Phase 2 |
0.72 | Intermediate Similarity | NPD1281 | Approved |
0.717 | Intermediate Similarity | NPD7033 | Discontinued |
0.7166 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.716 | Intermediate Similarity | NPD7003 | Approved |
0.7151 | Intermediate Similarity | NPD8313 | Approved |
0.7151 | Intermediate Similarity | NPD8312 | Approved |
0.7143 | Intermediate Similarity | NPD6386 | Approved |
0.7143 | Intermediate Similarity | NPD6385 | Approved |
0.7135 | Intermediate Similarity | NPD7240 | Approved |
0.7134 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7127 | Intermediate Similarity | NPD8150 | Discontinued |
0.7125 | Intermediate Similarity | NPD4477 | Approved |
0.7125 | Intermediate Similarity | NPD4476 | Approved |
0.7124 | Intermediate Similarity | NPD1470 | Approved |
0.7124 | Intermediate Similarity | NPD2797 | Approved |
0.7115 | Intermediate Similarity | NPD3268 | Approved |
0.7115 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7111 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7097 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7095 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD6355 | Discontinued |
0.7078 | Intermediate Similarity | NPD1019 | Discontinued |
0.7078 | Intermediate Similarity | NPD2798 | Approved |
0.7063 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7055 | Intermediate Similarity | NPD8166 | Discontinued |
0.7053 | Intermediate Similarity | NPD7435 | Discontinued |
0.7051 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7049 | Intermediate Similarity | NPD4287 | Approved |
0.7048 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7047 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7033 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7024 | Intermediate Similarity | NPD7458 | Discontinued |
0.7019 | Intermediate Similarity | NPD2438 | Suspended |
0.7006 | Intermediate Similarity | NPD6798 | Discontinued |
0.7006 | Intermediate Similarity | NPD7177 | Discontinued |
0.7006 | Intermediate Similarity | NPD1699 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD2654 | Approved |
0.6984 | Remote Similarity | NPD6781 | Approved |
0.6984 | Remote Similarity | NPD6777 | Approved |
0.6984 | Remote Similarity | NPD6779 | Approved |
0.6984 | Remote Similarity | NPD6776 | Approved |
0.6984 | Remote Similarity | NPD6782 | Approved |
0.6984 | Remote Similarity | NPD6780 | Approved |
0.6984 | Remote Similarity | NPD6778 | Approved |
0.6975 | Remote Similarity | NPD7266 | Discontinued |
0.6975 | Remote Similarity | NPD2343 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD7782 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD7783 | Phase 2 |
0.6954 | Remote Similarity | NPD6746 | Phase 2 |
PubChem CID   | 24899917 |
ChEMBL   | CHEMBL507058 |
ZINC   |
Molecular Weight:   | 288.06 |
ALogP:   | -1.5122 |
MLogP:   | 2.45 |
XLogP:   | 1.447 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 96.22 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |